Show simple item record

dc.contributor.authorLanglands, Fiona E.
dc.contributor.authorDodwell, David
dc.contributor.authorHanby, Andrew M.
dc.contributor.authorHorgan, Kieran
dc.contributor.authorMillican-Slater, Rebecca A.
dc.contributor.authorSpeirs, Valerie
dc.contributor.authorVerghese, Eldo T.
dc.contributor.authorSmith, Laura
dc.contributor.authorHughes, Thomas A.
dc.date.accessioned2018-07-26T23:02:41Z
dc.date.available2018-07-26T23:02:41Z
dc.date.issued2014-03-28
dc.identifier.citationLanglands , F E , Dodwell , D , Hanby , A M , Horgan , K , Millican-Slater , R A , Speirs , V , Verghese , E T , Smith , L & Hughes , T A 2014 , ' PSMD9 expression predicts radiotherapy response in breast cancer ' Molecular Cancer , vol. 13 , 73 . https://doi.org/10.1186/1476-4598-13-73en
dc.identifier.issn1476-4598
dc.identifier.otherPURE: 129547769
dc.identifier.otherPURE UUID: a2ed0006-cf81-4a12-a436-d926b8b74cae
dc.identifier.otherPubMed: 24673853
dc.identifier.otherPubMedCentral: PMC4230020
dc.identifier.otherScopus: 84901245817
dc.identifier.urihttp://hdl.handle.net/2164/10813
dc.descriptionThis work was supported by the Breast Cancer Campaign (FEL, LS, VS, TAH), the Breast Cancer Research Action Group (TAH), and the Medical Research Council (ETV). The funders had no roles in designing or carrying out the research, or in preparing the manuscript.en
dc.format.extent8en
dc.language.isoeng
dc.relation.ispartofMolecular Canceren
dc.rights© Langlands et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectpredictive markeren
dc.subjectradiotherapyen
dc.subjectproteasomeen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectMedical Research Council (MRC)en
dc.subject.lccRC0254en
dc.titlePSMD9 expression predicts radiotherapy response in breast canceren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/1476-4598-13-73


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record